Almirall Announces FDA Approval Of Updated Label For Seysara(R) (Sarecycline) Tablets

Seysara® is a novel oral antibiotic developed specifically for the treatment of acne It is FDA approved for the treatment of inflammatory lesions of non-nodular moderate to severe acne vulgaris in patients nine years of age and older(1) Seysara&r... Biopharmaceuticals, Dermatology, FDA Almirall, Seysara, Sarecycline, acne
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news